Hiroko Tonai‐Kachi

449 total citations
8 papers, 388 citations indexed

About

Hiroko Tonai‐Kachi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Hiroko Tonai‐Kachi has authored 8 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 2 papers in Pharmacology. Recurrent topics in Hiroko Tonai‐Kachi's work include Receptor Mechanisms and Signaling (3 papers), Neuropeptides and Animal Physiology (3 papers) and Inflammatory mediators and NSAID effects (2 papers). Hiroko Tonai‐Kachi is often cited by papers focused on Receptor Mechanisms and Signaling (3 papers), Neuropeptides and Animal Physiology (3 papers) and Inflammatory mediators and NSAID effects (2 papers). Hiroko Tonai‐Kachi collaborates with scholars based in Japan and United States. Hiroko Tonai‐Kachi's co-authors include Yasuhito Taniguchi, Katsuhiro Shinjo, Hiroyuki Ohshiro, Junji Takada, Kazunari Nakao, Akio Murase, Takako Okumura, Janice C. Parker, Shinichi Sakemi and Hiroyuki Nishida and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Hiroko Tonai‐Kachi

8 papers receiving 366 citations

Peers

Hiroko Tonai‐Kachi

MB

PHARM

CMN

PHYSI

BP

Hebe M. Guardiola‐Diaz United States

Dan Feng China

Claudia Keller Switzerland

Jemma Gatliff United Kingdom

M Brungs Germany

Elisa Canepa United States

Denise D. McKinley United States

Christina Unger Lithner Sweden

Jeffrey A. Heroux United States

Débora G. Flores Brazil

Hebe M. Guardiola‐Diaz United States

Hiroko Tonai‐Kachi

340 ×1.7

MB

62 ×0.6

PHARM

53 ×0.5

CMN

110 ×1.6

PHYSI

14 ×0.3

BP

Citations per year, relative to Hiroko Tonai‐Kachi Hiroko Tonai‐Kachi (= 1×) peers Hebe M. Guardiola‐Diaz

Countries citing papers authored by Hiroko Tonai‐Kachi

Since Specialization

Citations

This map shows the geographic impact of Hiroko Tonai‐Kachi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Tonai‐Kachi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Tonai‐Kachi more than expected).

Fields of papers citing papers by Hiroko Tonai‐Kachi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Tonai‐Kachi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Tonai‐Kachi. The network helps show where Hiroko Tonai‐Kachi may publish in the future.

Co-authorship network of co-authors of Hiroko Tonai‐Kachi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Tonai‐Kachi. A scholar is included among the top collaborators of Hiroko Tonai‐Kachi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Tonai‐Kachi. Hiroko Tonai‐Kachi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Mori, Hiroki, Hiroko Tonai‐Kachi, Yasuo OCHI, et al.. (2008). N-(2-Hydroxyethyl)-N,2-dimethyl-8-{[(4 R)-5-methyl-3,4-dihydro-2 H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a Novel, Potent, and Selective Acid Pump Antagonist for the Treatment of Gastroesophageal Reflux Disease. Journal of Pharmacology and Experimental Therapeutics. 328(2). 671–679. 22 indexed citations

2.

Taniguchi, Yasuhito, Hiroko Tonai‐Kachi, & Katsuhiro Shinjo. (2008). 5-Nitro-2-(3-Phenylpropylamino)benzoic Acid Is a GPR35 Agonist. Pharmacology. 82(4). 245–249. 24 indexed citations

3.

Murase, Akio, et al.. (2007). Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation. European Journal of Pharmacology. 580(1-2). 116–121. 48 indexed citations

4.

Murase, Akio, Yasuhito Taniguchi, Hiroko Tonai‐Kachi, Kazunari Nakao, & Junji Takada. (2007). In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP4 receptor antagonist. Life Sciences. 82(3-4). 226–232. 41 indexed citations

5.

Ohshiro, Hiroyuki, et al.. (2007). GPR35 is a functional receptor in rat dorsal root ganglion neurons. Biochemical and Biophysical Research Communications. 365(2). 344–348. 86 indexed citations

6.

Taniguchi, Yasuhito, Hiroko Tonai‐Kachi, & Katsuhiro Shinjo. (2006). Zaprinast, a well‐known cyclic guanosine monophosphate‐specific phosphodiesterase inhibitor, is an agonist for GPR35. FEBS Letters. 580(21). 5003–5008. 130 indexed citations

7.

Kim, Yoon-Jeong, Hiroyuki Nishida, Toshiyuki Saito, et al.. (2002). CJ-21,164, a New D-Glucose-6-phosphate Phosphohydrolase Inhibitor Produced by a Fungus Chloridium sp.. The Journal of Antibiotics. 55(2). 121–127. 9 indexed citations

8.

Sakemi, Shinichi, Hideo Hirai, Toshio Ichiba, et al.. (2002). Thielavins as Glucose-6-phosphatase (G6Pase) Inhibitors: Producing Strain, Fermentation, Isolation, Structural Elucidation and Biological Activities.. The Journal of Antibiotics. 55(11). 941–951. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact